KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Elanco Animal Health (ELAN) Cost of Revenue (2017 - 2025)

Elanco Animal Health's Cost of Revenue history spans 9 years, with the latest figure at $555.0 million for Q4 2025.

  • For Q4 2025, Cost of Revenue rose 10.78% year-over-year to $555.0 million; the TTM value through Dec 2025 reached $2.1 billion, up 5.94%, while the annual FY2025 figure was $2.1 billion, 5.94% up from the prior year.
  • Cost of Revenue for Q4 2025 was $555.0 million at Elanco Animal Health, up from $530.0 million in the prior quarter.
  • Across five years, Cost of Revenue topped out at $569.0 million in Q1 2021 and bottomed at $434.0 million in Q2 2023.
  • The 5-year median for Cost of Revenue is $505.5 million (2021), against an average of $505.0 million.
  • The largest YoY upside for Cost of Revenue was 86.15% in 2021 against a maximum downside of 14.43% in 2021.
  • A 5-year view of Cost of Revenue shows it stood at $510.0 million in 2021, then dropped by 12.16% to $448.0 million in 2022, then grew by 15.18% to $516.0 million in 2023, then dropped by 2.91% to $501.0 million in 2024, then grew by 10.78% to $555.0 million in 2025.
  • Per Business Quant, the three most recent readings for ELAN's Cost of Revenue are $555.0 million (Q4 2025), $530.0 million (Q3 2025), and $528.0 million (Q2 2025).